Pharyngitis is a disorder that is typically characterized by the inflammation of the pharynx. It is most commonly known as sore throat. It causes pain, discomfort and scratchiness in the throat that further leads to difficulty in swallowing. The most common cause of its occurrence is due to viral infections such as common cold, influenza and others. The early treatment is essential to relive the pain. The typical symptoms includes sneezing, headache, fatigue, runny nose, body aches, chills and others.
As per a recent research, about 70% of streptococcal infections of the respiratory tract are non-symptomatic, and these infections can cause serious non-supportive reaction. Pharyngitis is most commonly caused by viral infection such as common cold, influenza, and mononucleosis. It has been observed that self-medication for treating pharyngitis such as using antibiotics without knowing the exact cause deteriorates the disease condition and may last for several days.
Data Bridge Market Research analyses a growth rate in the pharyngitis treatment market in the forecast period 2023-2030. The expected CAGR of pharyngitis treatment market is tend to be around 4.9% in the mentioned forecast period. The market was valued at USD 2.20 billion in 2022, and it would grow upto USD 3.23 billion by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
The major countries covered in the pharyngitis treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to the presence of key manufacturers of the product is high and, increasing research and development activities.
Asia-Pacific dominates the market due to increased new research and developments on Pharyngitis Treatment market.
Request a Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pharyngitis-treatment-market
Key players operating in the pharyngitis treatment market include:
Bausch Health Companies Inc. (Canada.)
Accord Healthcare (U.K.)
Genentech, Inc (U.S.)
PLIVA (Croatia)
Pfizer Inc (U.S.)
Amneal Pharmaceuticals LLC. (U.S.)
Teva Pharmaceutical Industries Ltd (Israel)
Mylan N.V. (U.S.)
AbbVie Inc (U.S.)
GSK plc (U.K.)
Novartis AG (Switzerland)
ZAMBON COMPANY S.P.A (Italy)
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Global Pharyngitis Market - A Report by Fact.MRPharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat.
It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus.
Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage.
According to the medical professionals, around 50% of a sore throat or pharyngitis is caused by viral infection, while around 15-20% is caused by bacterial infection.Hence, throat lozenges are also being prescribed for people suffering from pharyngitis and it also offers temporary relief from cough and cold, which the most common cause of sore throat.
As per Randomized Controlled Trial (RCT) published recently in Canadian Medical Association Journal, found that probiotics and xylitol chewing gum have no effect on a sore throat or pharyngitis symptoms.
Hence, drug manufacturers are conducting research to develop new drugs to fight sore throat without causing any side-effects.Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global pharyngitis market.
Pharyngitis is the clinical term for an irritated throat.
Reasons for pharyngitis incorporate viral contaminations, like normal colds, and bacterial diseases, for example, bunch A Streptococcus.
Pharyngitis is a typical condition and infrequently a reason for concern.
Viral pharyngitis regularly clears up all alone inside a week or thereabouts.
In any case, realizing the reason can assist with peopling slender down their treatment alternatives.
This article takes a gander at the causes, transmission, and manifestations of pharyngitis.
